As the Founder and CEO of Aim Trials, I have over 18 years of experience in clinical research, project management, and regulatory compliance in both drug and medical device trials. I lead a team of research professionals who are dedicated to delivering high-quality, ethical, and innovative clinical studies in various therapeutic areas for both Pediatric and Adult Populations, with a focus on mental health.My mission is to shatter the mental health stigma within the community. I works closely with mental health organizations such as NAMI, Changes, and NOCD.Driven by a profound commitment to the well-being of our community, I have cultivated a visionary approach that encompasses a multi-specialty site integrated within a private practice. This unique synergy empowers our team of experienced investigators to lead with unmatched expertise in conducting Phase I-IV research trials.My aim is to provide exceptional service and value to our clients, partners, and patients, by leveraging my expertise in clinical research design, execution, and reporting, as well as my knowledge of the latest industry standards and best practices. Aim Trials has successfully participated in over 50 clinical trials in both Mental Health and General Health domains. Our patient database, which adheres to HIPAA regulations, now encompasses a substantial number of over 20,000 patients. In our prior studies we were able to enroll 35% Caucasians, 30% African-Americans, 15% Asians, 15% Hispanics, 1% American-Indians and 4% other.